What do you know about pivoting a tech company in the midst of a global pandemic?
Unfortunately, if you're an entrepreneur, you know a whole lot about this very thing. For Alex Bisignano and his team at Phosphorous, 2020 started off strong. They had a growing business delivering next-generation sequencing (NGS) genetics testing products. And then Covid happened. After watching his run rate drop to near zero in the space of a few weeks, Alex, his team, and his investors worked together to engineer a company-wide pivot. Leveraging their collective expertise in testing, Phosphorous released a critical new product to market: at-home Covid tests. Phosphorous' saliva-based Covid tests are now available to individuals and organizations, and the company went from near failure to closing out 2020 with surging revenue and a critical new business line that's helping individuals and organizations fight the Covid pandemic.
Alex talks to the Mikes about the challenges the company faced this year, as well as his own personal pivot from financial services to medical technology startups. He shares his advice for entrepreneurs looking to get into the medtech space, his thoughts on what it takes to turn a tanker ship, and he tells us where the future of genetics testing is heading. You can check out what they're building at Phosphorous.com.
Information
- Show
- Published5 March 2021 at 16:07 UTC
- Length42 min
- Season1
- Episode21
- RatingClean